Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound pioglitazone hydrochloride + glimepiride tablets in type 2 diabetes
CTR20140304Phase 2Active
- Sponsor
- Hainan Guoruitang Pharmaceutical
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glimepiride + pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Hainan Guoruitang Pharmaceutical. Started Apr 2014; status: active.
02
Drugs
glimepiride + pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20140304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140304.